Clinical Trials on Metastatic Hormone-Sensitive Prostate Cancer in Korea, Republic of
Total 1219 results
-
BayerNot yet recruitingNon-metastatic Castration-resistant Prostate Cancer | Metastatic Hormone-sensitive Prostate CancerKorea, Republic of
-
FutureChemCompletedMetastatic Castration-resistant Prostate CancerKorea, Republic of
-
FutureChemActive, not recruitingMetastatic Castration-resistant Prostate Cancer, mCRPCKorea, Republic of
-
SL VAXiGENRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)Korea, Republic of
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerKorea, Republic of, Japan, United States, Argentina, Australia, Belgium, Canada, Chile, Denmark, Finland, France, Germany, Israel, Italy, Netherlands, New Zealand, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, United...
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Samsung Medical CenterCompletedColorectal CancerKorea, Republic of
-
Korean Cancer Study GroupCompletedHormone Refractory Prostate CancerKorea, Republic of
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Hormone-sensitive Prostate CancerUnited States
-
Pharmicell Co., Ltd.TerminatedCastration Resistant Prostate Cancer, CRPCKorea, Republic of
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Seoul National University HospitalUnknownProstate Cancer Recurrent | Stage II Prostate Carcinoma | Stage III Prostate CarcinomaKorea, Republic of
-
GlaxoSmithKlineCompletedBenign Prostatic Hyperplasia | Prostate Cancer | Neoplasms, ProstateKorea, Republic of
-
Asan Medical CenterUnknownCastration-resistant Prostate CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingAdvanced, Refractory CancerKorea, Republic of
-
Samsung Medical CenterCompletedMetastatic CancerKorea, Republic of
-
Samsung Medical CenterRecruitingMetastatic CancerKorea, Republic of
-
Seoul National University HospitalCompletedBenign Prostatic Hyperplasia | Prostate CancerKorea, Republic of
-
PharmAbcineCompletedMetastatic Cancer | Advanced CancerKorea, Republic of
-
Asan Medical CenterBiomaterials Research Center, Korea Institute of Science and Technology (KIST)... and other collaboratorsRecruitingProstate CancerKorea, Republic of
-
Asan Medical CenterBumjin Lim; Dalsan Yoo; Hyung Keun Park; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim; Kye... and other collaboratorsRecruitingProstate CancerKorea, Republic of
-
Seoul National University HospitalCompletedProstate CancerKorea, Republic of
-
Gangnam Severance HospitalUnknownProstate CancerKorea, Republic of
-
Yonsei UniversityCompletedProstate CancerKorea, Republic of
-
Yonsei UniversityCompletedProstate CancerKorea, Republic of
-
Yonsei UniversityCompletedProstate CancerKorea, Republic of
-
Ferring PharmaceuticalsCompleted
-
Ji Youl LeeUnknown
-
Asan Medical CenterCompletedProstate CancerKorea, Republic of
-
Asan Medical CenterCompletedProstate CancerKorea, Republic of
-
HanAll BioPharma Co., Ltd.Completed
-
Asan Medical CenterCompletedProstate CancerKorea, Republic of
-
Yonsei UniversityCompletedProstate CancerKorea, Republic of
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
-
Seoul National University HospitalRecruitingProstate CancerKorea, Republic of
-
Asan Medical CenterCompletedProstate CancerKorea, Republic of
-
Yonsei UniversityUnknownProstate CancerKorea, Republic of
-
Yonsei UniversityCompletedProstate CancerKorea, Republic of
-
Janssen Research & Development, LLCActive, not recruitingMetastatic Castration-sensitive Prostate CancerUnited States, Italy, China, Korea, Republic of, Canada, Australia, United Kingdom, Hungary, France, Taiwan, Thailand, Germany, Malaysia, Denmark, Russian Federation, New Zealand, Ukraine, Bulgaria, Israel, Spain, Turkey, Sweden, Cz... and more
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
Samsung Medical CenterRecruitingMetastatic CancerKorea, Republic of
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
Asan Medical CenterCompletedProstate CancerKorea, Republic of
-
Yonsei UniversityCompletedProstate Cancer | Robotic SurgeryKorea, Republic of
-
CJ Bioscience, Inc.RecruitingMelanoma | NSCLC | Metastatic Cancer | Advanced Solid Tumor | Advanced Cancer | HNSCCKorea, Republic of
-
AstraZenecaActive, not recruitingHormone-Sensitive Prostate CancerUnited States, Belgium, Spain, Canada, Poland, Argentina, India, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Germany, Korea, Republic of, Brazil, Mexico, Peru, Philippines, China, United Kingdom, Hong Kong, Israel, ... and more
-
Seoul St. Mary's HospitalNational IT Industry Promotion AgencyRecruitingProstate CancerKorea, Republic of
-
Samsung Medical CenterCompletedProstate CancerKorea, Republic of
-
Yonsei UniversityEnrolling by invitationPlatinum-sensitive Recurrent BRCA Wild Type Ovarian CancerKorea, Republic of